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Abstract
Background: The weekly proportion of laboratory tests that are positive for influenza is used in public health surveillance
systems to identify periods of influenza activity. We aimed to estimate the sensitivity of influenza testing in Canada based
on results of a national respiratory virus surveillance system.
Methods and Findings: The weekly number of influenza-negative tests from 1999 to 2006 was modelled as a function of
laboratory-confirmed positive tests for influenza, respiratory syncytial virus (RSV), adenovirus and parainfluenza viruses,
seasonality, and trend using Poisson regression. Sensitivity was calculated as the number of influenza positive tests divided
by the number of influenza positive tests plus the model-estimated number of false negative tests. The sensitivity of
influenza testing was estimated to be 33% (95%CI 32–34%), varying from 30–40% depending on the season and region.
Conclusions: The estimated sensitivity of influenza tests reported to this national laboratory surveillance system is
considerably less than reported test characteristics for most laboratory tests. A number of factors may explain this
difference, including sample quality and specimen procurement issues as well as test characteristics. Improved diagnosis
would permit better estimation of the burden of influenza.
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Introduction
Although influenza virus infection is associated with consider-
able morbidity and mortality[1–3], laboratory confirmation of
clinical illness is the exception rather than the rule. Clinicians do
not routinely seek laboratory confirmation for several reasons:
diagnosis will often not alter patient management, a paucity of
real-time, accurate, inexpensive testing methods [4] and because
influenza is not recognized as the etiology of the clinical
presentation[5]. Accurate diagnosis of influenza-like illness,
however, could improve clinical care through reduced use of
antibiotics and ancillary testing, and more appropriate use of
antiviral therapy [6]. Although rapid influenza tests such as point-
of-care tests are purported to generate results in a timely fashion to
influence clinical care, the performance characteristics of the
currently available tests are sub-optimal [7]. New technologies
with improved sensitivity such as reverse-transcriptase polymerase
chain reaction (RT-PCR) [8] as well as the use of more effective
collection systems such as the flocked nasopharyngeal swab
compared to traditional rayon wound swabs, and the recommen-
dation to collect more ideal specimens, such as nasopharyngeal
swabs rather than throat swabs are likely to improve diagnostic
sensitivity [9–12]. The performance characteristics of currently
available tests for influenza vary considerably and the overall
sensitivities of these tests when used in routine practice are also
dependent on the type of specimen collected, the age of the patient
and point in their illness in which they are sampled [4,9,13–15].
We sought to estimate the sensitivity of influenza testing based
on results of a national respiratory virus surveillance system using a
model-based method [1,2,16–18].
Methods
Sources of data
Weekly respiratory virus identifications from September 1999 to
August 2006 were obtained from the Respiratory Virus Detection
Surveillance System (RVDSS), Public Health Agency of Canada
[19,20]. The RVDSS collects, collates, and reports weekly data
from participating laboratories on the number of tests performed
and the number of specimens confirmed positive for influenza,
respiratory syncytial virus (RSV), para-influenza virus (PIV), and
adenovirus. Specimens are generally submitted to laboratories by
clinicians in the course of clinical care, and by clinicians
participating in one of our national influenza surveillance
programs, (FluWatch [20]). Indicators of influenza activity are
reported year round on a weekly basis to the FluWatch program.
The RVDSS is supplemented by case reports of influenza positive
cases [19,21]. From the case reports, influenza A was confirmed in
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months of June through September. Infants and children under
the age of 5 years accounted for 25% of the influenza A positive
tests, and persons over the age 65 years another 35%.
Unfortunately, FluWatch surveillance data does not provide the
total number of tests by age. Testing practices are known to be
varied [22,23]. The predominant testing methods used for
influenza detection varied considerably by province or laboratory
and over time. For the 2005/06 season a survey of laboratory
techniques in current use indicated that culture accounted for 44%
of the diagnostic tests with RT-PCR, rapid antigen tests and direct
fluorescent-antibody assay (DFA) accounting for 21%, 19%, and
16% respectively[23].
Statistical Analysis
The weekly number of tests negative for influenza was
modelled, using Poisson regression, as a function of viral
identifications for influenza, RSV, adenovirus and PIV as well as
a baseline consisting of seasonality, trend and holiday variables.
The estimated baseline implicitly accounts for influenza tests on
specimens taken from patients with respiratory infections due to
respiratory pathogens other than the four viruses captured in the
RVDSS, as long as both the testing behaviour of clinicians and
respiratory illnesses caused by other respiratory pathogens follow a
consistent seasonal pattern as prescribed by the model (see below,
parameters b1 to b4).
The Poisson regression model with a linear link function was
estimated using SAS [24] PROC GENMOD:
^ F FluNegw~
X 12
m~1
b1,mMonw,mz
X 2006
y~2000
b2,yFYw,y
zb3Holidayswzb4Xmasw
zb5InflAwzb6InflBwzb7RSVpw
zb8Adenopwzb9Parapw
where ^ F FluNegw is the predicted number of negative tests for
influenza for week w; Monw,m an indicator variable for each month;
FYw,y an indicator variable for the influenza season (year running
from September to August); Holidaysw and Xmasw variables
indicating holidays; InflAw, InflBw, RSVpw, Adenopw, Parapw the
weekly number of tests confirmed positive for influenza A and B,
RSV, adenovirus and para-influenza virus respectively. A
regression model approach facilitates the simultaneous estimation
of the effects of influenza activity on the number of influenza-
negative tests while controlling for other factors. The model was
further stratified by influenza season by including separate
parameters for each season (b5y rather than b5).
Coefficients b5 to b9 are multipliers. The weekly number of
influenza negative tests estimated to be falsely negative is given by
b5 InflAw+b6 InflBw. The weekly number of influenza negative tests
attributed to RSV is given by b7 RSVpw., and similarly for
adenovirus and PIV. For each positive influenza A test, an
additional b5 tests above baseline were performed and found to be
negative. By specifying a linear link, a value of 0.33, say, for
coefficient b5, means that for every test for which influenza A was
confirmed, 0.33 additional tests, on average, were performed on
truly influenza A positive specimens and found to be negative –
which corresponds to a sensitivity of 75%.
Sensitivity was calculated as the number of influenza positive
tests divided by the number of influenza positive tests plus the
model-estimated number of false negative tests, or equivalently,
the estimates of sensitivity for influenza A and B are given by 1/
(1+b5) and 1/(1+b6) respectively. The false negative rate is 1 minus
sensitivity. While the null value for b5 is zero, which indicates no
statistical association between the number of influenza positive
tests and the number of influenza negative tests, the corresponding
null value for sensitivity is 1.
For each test confirmed positive for RSV, on average b7 tests were
performed for influenza and found to be negative for influenza. These
b7 tests are attributed to an RSV infection, however the number of
influenza-negative tests that actually tested positive for RSV is
unknown. If all specimens had been tested for the same viruses (panel
tests), 1/b7 would correspond to the sensitivity for RSV testing, and
the sensitivity for adenovirus and PIV given by 1/b8 and 1/b9
respectively. Some laboratories are known to test for viruses
sequentially [22], and so 1/b7 -1 / b9 were not interpreted as estimates
of the sensitivity for other viruses. Sequential testing may occur if a
rapid test for influenza is negative and the laboratory then performs
PCR or culture testing. Similarly in young children with a respiratory
illness in the winter, rapid tests for RSV infection may be performed
first, and only specimens with negative results submitted for
subsequent testing for influenza or other respiratory viruses [25]. By
contrast, many laboratories conduct panel tests for multiple viruses for
ease of handling, decreased patient sampling, and recognition that co-
infection can occur. Either form of sequential testing would not bias
the estimate of sensitivity applicable to test results reported to RVDSS,
though significant use of rapid antigen tests in the laboratories
reporting to RVDSS would reduce the overall sensitivity. As a single
specimen may undergo multiple tests, the false-negative rate
applicable to a specimen that has undergone multiple tests would be
expected to be much lower than the system average for individual
tests. Parameters b1. to b4 account for trends and the seasonality of
truly negative specimens (patients presenting with other acute
respiratory infections).
Results
Over 50,000 tests for influenza were reported to the RVDSS
each year, peaking in 2004/05 at 101,000. Overall 10% of the
influenza tests were positive for influenza, ranging from 4% to
13% depending on the season. The proportion positive for RSV,
parainfluenza and adenovirus averaged 9%, 3% and 2%
respectively. As seen in Figure 1, no virus was identified in 75%
of specimens submitted for testing (white area under the curve).
Even for the winter months of December through April, one of
these 4 viruses was identified on average in no more than 30% of
the specimens. The strong and consistent synchronization of
negative tests with influenza positive tests, as seen in Figure 1, is
suggestive that false negative results contributed to the large
number of negative tests during periods of influenza activity.
The sensitivity for influenza A testing averaged 33.7% (with
model-estimated 95% confidence intervals of 33.3–34.1) for the
1999/2000–2005/06 period. Influenza B testing had a similar
estimated sensitivity at 34.7 (95% CI 33.4–36.1). Estimated
sensitivities varied somewhat from season to season, generally
ranging from 30%–40% (Table 1), and provincial level estimates,
as well, were within a similar range. Stratifying by province or
season produced similar estimates for the sensitivity of influenza A
testing: 32% (95% CI 30–34) and 36% (95% CI 33–41)
respectively. Estimates of sensitivity based on test results reported
to the RVDSS for individual laboratories with sufficient data to fit
the model showed significant variation, with estimates of sensitivity
ranging from 25–65%. As expected, laboratories using primarily
rapid antigen tests had lower estimated sensitivities, and
laboratories that used PCR methods had higher sensitivity
Influenza Test Sensitivity
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primarily to the 2005/06 survey. As well, additional irregularities
were noticed in the laboratory data and not all laboratories
provided sufficient data to fit the model.
Figure 2 illustrates a good model fit where the weekly number of
influenzanegativetestsiswellexplainedbythemodelcovariates,with
a few exceptions. Firstly, it is evident that additional specimens were
tested during the SARS period, as indicated by the period where the
number of weekly influenza negative tests exceeded the expected
number, or equivalently, a period of successive positive residuals.
Residuals typically capture random variation; hence represent tests
that can not be allocated based on the specified model. In addition to
the SARS period, testing appears to have been elevated for a number
of weeks in January 2000 during the peak of the 1999/2000 A/
Sydney/05/97 (H3N2) season in which respiratory admissions were
unusually elevated [26,27], and in December 2003, when an elevated
risk of paediatric deaths associated with the A/Fujian/411/02
(H3N2) strain [28] was identified in the US. As these periods
corresponded to a period of heightened public awareness due to
severe influenza outbreaks, parameter estimation was repeated
without these data points. Exclusion of these data points did not
alter the sensitivity estimate for influenza.
The attribution of influenza negative test results to influenza
and other viruses is illustrated in Figure 3. The baseline curve is
the model estimate of the number of tests that were likely truly
negative for all four viruses tested. A reduction in specimen
collection and testing, primarily for viruses other than influenza, is
also evident over the Christmas period (Figure 3).
The weekly proportion of tests confirmed positive for influenza
peaked each season at 15 to 30%. Accounting for the model estimated
false negative rate suggests that during periods of peak influenza
activity, 40–90% of tests were performed on specimens taken from
persons recently infected with influenza. Influenza was confirmed in
only 14% of specimens sent for testing over the winter period, whereas
the sensitivity estimate would imply that up to 40% of influenza tests
could be attributed to an influenza infection. The corresponding
figures for the whole year indicate that 10% of specimens were
confirmed positive for influenza and 30% of influenza tests could be
model-attributed to an influenza infection annually.
Despite a relatively large number of tests in the off-season, the
number of influenza positive tests was almost negligible; suggesting
that the false positive rate applicable to RVDSS influenza testing is
minimal.
Discussion
The model estimated sensitivity based on influenza test results
reported to the RVDSS of 30–40% is much lower than the
standard assay sensitivities documented in the literature. Standard
sensitivities for diagnostic procedures used by participating
Figure 1. RVDSS viral identifications. Weekly number of specimens tested for influenza is shown with the number of tests confirmed positive for
influenza (A and B), adenovirus, parainfluenza virus, and RSV. Data is presented ignoring co-infection and sequential testing, so the white area under
the curve, which corresponds to 75% of tests, represents the minimum number of specimens that were negative for all 4 viruses.
doi:10.1371/journal.pone.0006681.g001
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RT-PCR tests, averaging 75% for the study period [23]. As
performance characteristics of specific tests are generally based on
high quality specimens, the difference of approximately 40% is
likely linked to any one of many operational procedures that
affects the quality of the specimen and its procurement. Unlike
validation studies, our samples are taken from a variety of clinical
settings and processed with a variety of procedures across the
country. As well, variation in the indications for diagnostic testing
may vary across the country.
As there are many other respiratory pathogens that are not
routinely tested for, or reported to the RVDSS, including human
metapneumovirus (hMPV), coronaviruses, and rhinoviruses for
which patients may seek medical care and present with influenza
like illness [29–32], a large proportion of negative test results was
expected. The overall model fit, and the general consistency of
the sensitivity estimates, suggests that these many respiratory
viruses were reasonably accounted for by the seasonal baseline
and that the strong association between the number of influenza
positive and influenza negative tests on a weekly basis is
indicative of a significant number o ff a l s en e g a t i v er e s u l t s ,r a t h e r
than the activity of another virus or viruses exactly synchronous
with influenza. The latter would bias the estimated sensitivity of
the system downwards. However, to significantly and consistently
bias the estimate, the degree of synchronization would have to be
fairly strong, persist over the whole study period, and occur in all
provinces. Synchronization was not observed among the RVDSS
viruses (influenza A, influenza B, RSV, adenovirus and PIV), and
elsewhere other viruses such as rhinovirus, coronavirus and
hMPV accounted for only a small proportion of the viral
identifications and were not found to be synchronized with
influenza [33]. As well, patients may present for care due to a
secondary bacterial infection. While any specimen would likely
test negative as the virus, at this point, is likely not detectable, the
model would statistically attribute a negative test in this case to
the primary infection; one of the four RVDSS viruses or to the
seasonal baseline that represents other respiratory infections,
depending on the level of viral activity at the time of the test. This
is not considered a source of bias.
The large variation in false negative rates estimated for
individual laboratories reporting to the RVDSS suggests that
standardization of sample procurement, testing and reporting
procedures would likely reduce the overall false negative rate.
The accuracy of diagnostic tests is known to be affected by the
quality of the specimen [10,11], its handling, the timing of
collection after symptom onset, and the age of the patient
[14,15]. Even with the most sensitive molecular methodologies,
yield was shown to be strongly related to the time since onset of
symptoms [9,14], with a 3-fold decline in proportion positive
within 3 to 5 days after onset of symptoms for both RT-PCR and
culture procedures. For most laboratory tests, specimen procure-
ment within 72 hours of from the onset of symptoms is
recommended [6], yet patients often present much later in the
course of illness. Estimates of the median time since onset of
symptoms suggest a delay of 3 and 5 days for outpatient and
inpatients respectively [15], however these estimates are limited
to patients with laboratory confirmed influenza. In addition,
there are inherent differences in the performance characteristics
of the currently used diagnostic tests [4,6,8,34–38]. Lack of
standardization between diagnostic tests and algorithms used in
different laboratories reporti n gt ot h eR V D S Sa d d st ot h i s
complexity. The routine use of RT-PCR testing has only recently
become available in Canada (only 20% of tests used RT-PCR
methods as of 2005/06 [23]), but increased use of this modality is
expected to improve accuracy.
Population or system level sensitivity estimates that include the
effects of sample quality are limited. Grijalva and colleagues [39]
estimated the diagnostic sensitivity in a capture recapture study of
children hospitalized for respiratory complications at 69% for a
RT-PCR based system and 39% for a clinical-laboratory based
system (passive surveillance of tests performed during clinical
practice, and using a variety of commercially available tests).
Though the expected proportion of influenza tests that were
due to influenza infections is unknown and variable, our model
estimate of 30% appears plausible. Cooper and colleagues [33]
attributed 22% of telephone health calls for cold/flu to influenza
over two relatively mild years, and elsewhere 20% of admissions
for acute respiratory infections (including influenza) in adults
aged 20–64 years were attributed to influenza, and 42% for
seniors [1].
While there are limitations with this approach, there are no
other simple alternatives to assist in the interpretation of the
RVDSS data. It would have been helpful to analyze data based on
each specimen sent for testing. With only the number of weekly
tests and number of positive results, we were unable to calculate
the number of specimens that were actually found to be negative
for all four viruses, or to estimate the extent of co-infection. Co-
infection, which was not accounted for in our model, could result
in an under-estimation of the number of falsely negative tests, as
the attribution of an influenza negative test that was actually co-
infected with influenza and another respiratory virus would have
to be split between the viruses. With auxiliary information
associated with each specimen, model estimates of false negative
rates based on, for example, test type, time since onset of
Table 1. Model Estimates of Sensitivity for Influenza A
Testing as Reported to the RVDSS, by Influenza Season.
Season Sensitivity 95% CI
1999/00 34% (32%–38%)
2000/01 80% (ns) (39%–100%)
2001/02 48% (41%–56%)
2002/03 n/a
2003/04 35% (32%–37%)
2004/05 34% (32%–37%)
2005/06 35% (30%–44%)
Weighted Average 36% (33%–41%)
Note: Estimates of sensitivity by influenza season were obtained by estimating
separate b5,y parameters, one for each season. Noting that the null value for
sensitivity is 100%, as 100% sensitivity implies that there should no association
between the number of influenza negative and influenza positive tests, the
season specific estimates appear to be reasonably consistent. Season specific
differences in the estimated sensitivity may be due to irregular reporting and
the tendency of data irregularities to bias the model parameters b5,y towards
the null, or sensitivity towards 1. A value of 100% for sensitivity implies that
there is no association between the number of influenza negative and influenza
positive tests. The 2000/01 and 2002/03 season estimates (both H1N1/B
seasons) were uninformative. This lack of statistical significance and wide
confidence intervals were attributed to the relatively small number of influenza
A positive specimens in these two H1N1 seasons. A shift in influenza A
confirmations towards younger ages was noted during the H1N1 seasons.
Testing a larger proportion of children may result in an improvement in the
overall test sensitivity.
ns: Not statistically significant. The null value for sensitivity is 100%. With 100%
sensitivity no association between the number of influenza negative and
influenza positive tests would be expected.
n/a: Not available. Estimate was out of range and not statistically significant.
doi:10.1371/journal.pone.0006681.t001
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allowed us to explore the reasons for the high false negative rates.
As the false negative rate appears to be laboratory dependant (data
not shown), this estimated range is applicable only to the RVDSS
for the study period. A significant reduction in the false negative
rate is anticipated as methods become standardized and with the
uptake of the new RT-PCR methods. As positive results,
particularly for culture, are often obtained a week or more after
the specimen was received, some positive results may have been
reported in a different week than the test. Multiple test results for a
single specimen may have also contributed to reporting irregular-
ities. These irregularities would tend to bias the estimated
parameter towards zero, and hence the estimated sensitivity
towards 1. Considering the overall model fit and the relative
severity of influenza [1], we conclude that our estimate of
sensitivity may be slightly over-estimated (number of false
negatives under-estimated).
Poor test sensitivity contributes to the chronic under-
estimation of the burden of influenza in the general population.
Since estimates of the burden of illness drive planning for
preventive and therapeutic interventions, it is important to
improve all aspects leading to improved diagnostic accuracy. We
have illustrated a simple method that uses the surveillance data
itself to estimate the system wide sensitivity associated with the
weekly proportion of tests confirmed positive. Although our
estimate of sensitivity is only applicable to the interpretation of
the RVDSS data over the study period, similar estimates for
specific cohorts or laboratory procedures may help guide further
investigation into the reasons for the large number of false
negative test results. The capacity for improved diagnostic
accuracy will ultimately improve our understanding of the
epidemiology of influenza.
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Figure 2. Model predicted number of tests negative for influenza. The weekly number of influenza tests not confirmed positive for influenza
was modelled as a function of viral identifications for influenza, RSV, adenovirus and parainfluenza, seasonality, and trend using Poisson regression.
Identified outliers, corresponding to periods with irregular testing were excluded from the model. The baseline accounts for routine tests in the
hypothetical absence of influenza, RVS, adenovirus and parainfluenza activity.
doi:10.1371/journal.pone.0006681.g002
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